Form 8-K - Current report:
SEC Accession No. 0001104659-24-127228
Filing Date
2024-12-10
Accepted
2024-12-10 16:43:49
Documents
14
Period of Report
2024-12-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2430664d1_8k.htm   iXBRL 8-K 56161
2 EXHIBIT 3.1 tm2430664d1_ex3-1.htm EX-3.1 6787
  Complete submission text file 0001104659-24-127228.txt   242467

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20241205.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20241205_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20241205_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2430664d1_8k_htm.xml XML 3796
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 241539096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)